Skip to main content
MASIMO CORP logo

MASIMO CORP — Investor Relations & Filings

Ticker · MASI ISIN · US5747951003 LEI · 549300Q4A8JK0PIYCU29 US Manufacturing
Open in API
Filings indexed 1,253 across all filing types
Latest filing 2023-02-09 Major Shareholding Noti…
Country US United States of America
Listing US MASI

About MASIMO CORP

https://www.masimo.com/

Masimo is a global medical technology company that develops, manufactures, and markets a wide array of noninvasive patient monitoring technologies. The company's core offering is its proprietary Signal Extraction Technology (SET®) pulse oximetry, renowned for its ability to provide accurate measurements during patient motion and low peripheral perfusion. Masimo's product portfolio also includes advanced solutions for brain function monitoring (SedLine®), regional oximetry (O3®), and integrated patient monitoring and connectivity platforms like Root®. These technologies are designed to improve patient outcomes, enhance patient safety, and streamline clinical workflows in various healthcare settings, including hospitals, emergency medical services, and home care. The company focuses on creating innovative solutions that empower clinicians with reliable data to make critical care decisions.

Recent filings

Filing Released Lang Actions
SCHEDULE 13G/A
Major Shareholding Notification
2023-02-09 English
FORM 8-K
Board/Management Information Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated February 5, 2023. It announces amendments to the company's bylaws, specifically the adoption of amended and restated bylaws by the Board of Directors. The content focuses on governance changes rather than financial results or detailed reports. The document includes a summary of the bylaw amendments and references the full text of the amended bylaws as an exhibit. There are no financial statements or earnings data presented, nor is this a proxy solicitation or voting results announcement. The primary subject is changes to corporate governance documents, which fits the category of Board/Management Information (MANG). The document length is 4402 characters, which is relatively short but contains substantive information about board-approved governance changes, not just an announcement of a report publication. Therefore, the best classification is MANG with high confidence.
2023-02-06 English
Major Shareholding Notification 2023
Major Shareholding Notification
2023-01-26 English
Major Shareholding Notification 2023
Major Shareholding Notification
2023-01-20 English
8-K
Regulatory Filings Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce significant events or disclosures by a company. The text references a Notice of Final Initial Determination on a patent infringement investigation and a related press release, both attached as exhibits. There are no financial statements or detailed financial data presented, nor is this an annual or quarterly report. The document is not a certification or a proxy statement, but a regulatory disclosure of a legal proceeding update. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous SEC filings that do not fit other specific categories.
2023-01-11 English
Major Shareholding Notification 2023
Major Shareholding Notification
2023-01-10 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.